BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹176 Cr | ₹153 Cr | ₹148 Cr | ₹130 Cr | ₹90 Cr |
What is the latest Total Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹176 Cr |
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹90 Cr |
How is Total Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹176 Cr | 14.67 | |
| Mar2025 | ₹153 Cr | 3.65 | |
| Mar2024 | ₹148 Cr | 13.97 | |
| Mar2023 | ₹130 Cr | 43.75 | |
| Mar2022 | ₹90 Cr | - | |
Compare Total Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹949.3 Cr | 8.2% | 32.4% | 278.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 8.2% |
32.4% |
278.5% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses